Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

A longitudinal study of the cause and consequences of changes in diversification in the U.S. pharmaceutical industry 1977–1986

16 references·16 citing·37 second hopsampled

FromToDepth

this work references cited by second hop· second hop is a sample of the most-cited connections

References

1995The Theory of the Growth of the Firm13,922 cited
1981Principles of Corporate Finance.3,634 cited
1973Industry Structure, Market Rivalry, and Public Policy2,402 cited
1975Strategy, structure, and economic performance2,066 cited
1982Towards an economic theory of the multiproduct firm2,001 cited
1985Diversification strategy, profit performance and the entropy measure1,572 cited
1982Diversification strategy and profitability1,373 cited
1964The Economic Theory of ‘Managerial’ Capitalism1,219 cited
1964The Economic Theory of `Managerial' Capitalism.969 cited
1988Tobin's q and the Importance of Focus in Firm Performance955 cited
1989Research on corporate diversification: A synthesis777 cited
1988Transaction cost analysis of strategy‐structure choice705 cited
1981Performance differences in related and unrelated diversified firms636 cited
1985The Co-operative Game Theory of the Firm.570 cited
1981Corporate economic performance: Diversification strategy versus market structure566 cited
1985PRODUCT-MARKET DIVERSIFICATION AND MARKET POWER.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

333 cited

Cited by

1992POWER IN TOP MANAGEMENT TEAMS: DIMENSIONS, MEASUREMENT, AND VALIDATION.2,389 cited
2001An examination into the causal logic of rent generation: contrasting Porter's competitive strategy framework and the resource‐based perspective1,113 cited
2000Curvilinearity in the diversification-performance linkage: an examination of over three decades of research1,101 cited
2001Decoupling Policy from Practice: The Case of Stock Repurchase Programs817 cited
2008Environmental context, managerial cognition, and strategic action: an integrated view728 cited
2013The Double-Edged Nature of Board Gender Diversity: Diversity, Firm Performance, and the Power of Women Directors as Predictors of Strategic Change485 cited
2002Sustained Competitive Advantage: Temporal Dynamics and the Incidence and Persistence of Superior Economic Performance426 cited
2001Second-Order Imitation: Uncovering Latent Effects of Board Network Ties319 cited
2012Move to the Beat—Rhythms of Change and Firm Performance280 cited
1993Innovative productivity and returns to scale in the pharmaceutical industry258 cited
1995Strategy and environment as determinants of performance: Evidence from the Japanese machine tool industry223 cited
1993The Multidivisional Structure: Organizational Fossil or Source of Value?184 cited
1996Technological learning, strategic flexibility, and new product development in the pharmaceutical industry153 cited
2017Redirecting Research Efforts on the Diversification–Performance Linkage: The Search for Synergy127 cited
2000Internal knowledge generation: the research laboratory and innovative productivity in the pharmaceutical industry110 cited
1992MEASUREMENT OF FIRM DIVERSIFICATION: IS IT ROBUST?107 cited